Buscar resultados de ensayos clínicos
Polycystic Kidney, Autosomal Dominant - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2007-12-31 Intervenciones: Drug: Tetracosactin 1 microgram tetracosactin, intravenous injection, once for the test |
Completed |
Nombre del estudio: 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2011-10-11 Intervenciones:
|
Recruiting |
Nombre del estudio: A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Fecha: 2017-03-27 Intervenciones: Other: High Water Intake After 6 months of usual, unchanged diet and fluid intake, participants will be |
Completed |
Nombre del estudio: Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Fecha: 2006-06-22 Intervenciones:
|
Completed |
Nombre del estudio: Water as Therapy in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2008-09-24 Intervenciones: Other: Water prescription Water prescription in 12 to 16 equally divided doses |
Completed |
Nombre del estudio: Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2006-12-20 Intervenciones:
|
Completed |
Nombre del estudio: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Study 156-04-001] Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2009-02-09 Intervenciones: Drug: OPC-41061 orally administered at 15 mg twice daily (morning and evening) for a maximum of 3 years. |
Terminated |
Nombre del estudio: Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency Condición: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Fecha: 2010-10-12 Intervenciones:
|
Completed |
Nombre del estudio: A Long-term Administration Study of OPC-41061 in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (2) [Extension of Study 156-05-002] Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2009-11-27 Intervenciones: Drug: OPC-41061 Repeated oral administration at doses of 15 mg twice daily (morning and evening) |
Not yet recruiting |
Nombre del estudio: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condición: Autosomal Dominant Polycystic Kidney Disease Fecha: 2016-04-08 Intervenciones: Device: Vessix Renal denervation using radio-ablation |